Full dose, half dose, or discontinuation of etanercept biosimilar in early axial spondyloarthritis patients: a real-world study in China :: Library Catalog

library@stipram.ac.id (0274) 485 650

Pengumuman Berita Terbaru PMB

Full dose, half dose, or discontinuation of etanercept biosimilar in early axial spondyloarthritis patients: a real-world study in China

oleh: Kun-Peng Li, Jing-Yu Jin, Jin-Shui Yang, Yan Li, Wei Zhao, Gui Luo, Jian Zhu, Jiang-Lin Zhang, Feng Huang

Format:	Article
Diterbitkan:	Termedia Publishing House 2018-06-01

Deskripsi

Subjek

axial spondyloarthritis; tnf blockers; etanercept biosimilar; dose reduction; remission